Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 21612-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#21612-1-AP, RRID:AB_10858924
- Product name
- PFTK1 antibody
- Antibody type
- Polyclonal
- Description
- PFTK1 antibody (Cat. #21612-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references 5-Hydroxytryptamine promotes non-small cell lung cancer metastasis via the SNRPG/WT1/CDK14 Axis.
Methylation-modulated PFTK1 regulates gefitinib resistance via Wnt/β-catenin signaling in EGFR mutant non-small-cell lung cancer cells.
Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus.
MiR-205 Inhibits Sporadic Vestibular Schwannoma Cell Proliferation by Targeting Cyclin-Dependent Kinase 14.
MiR-542-3p, a microRNA targeting CDK14, suppresses cell proliferation, invasiveness, and tumorigenesis of epithelial ovarian cancer.
CDK14 expression is down-regulated by cigarette smoke in vivo and in vitro.
Sun J, Liu CG, Chen S, Zhou H, Liu X, Wang FR, Luo YW, Zang D, Chen J
Molecular biomedicine 2025 Sep 29;6(1):69
Molecular biomedicine 2025 Sep 29;6(1):69
Methylation-modulated PFTK1 regulates gefitinib resistance via Wnt/β-catenin signaling in EGFR mutant non-small-cell lung cancer cells.
Jia X, Tian J, Chen P, Dong J, Li L, Chen D, Zhang J, Liao D, He Z, Luo K
Communications biology 2024 Dec 19;7(1):1649
Communications biology 2024 Dec 19;7(1):1649
Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus.
Goad DW, Bressy C, Holbrook MC, Grdzelishvili VZ
Molecular therapy oncolytics 2022 Mar 17;24:59-76
Molecular therapy oncolytics 2022 Mar 17;24:59-76
MiR-205 Inhibits Sporadic Vestibular Schwannoma Cell Proliferation by Targeting Cyclin-Dependent Kinase 14.
Yin X, Huo Z, Yan S, Wang Z, Yang T, Wu H, Zhang Z
World neurosurgery 2021 Mar;147:e25-e31
World neurosurgery 2021 Mar;147:e25-e31
MiR-542-3p, a microRNA targeting CDK14, suppresses cell proliferation, invasiveness, and tumorigenesis of epithelial ovarian cancer.
Li J, Shao W, Feng H
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2019 Feb;110:850-856
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2019 Feb;110:850-856
CDK14 expression is down-regulated by cigarette smoke in vivo and in vitro.
Pollack D, Xiao Y, Shrivasatava V, Levy A, Andrusier M, D'Armiento J, Holz MK, Vigodner M
Toxicology letters 2015 Apr 16;234(2):120-30
Toxicology letters 2015 Apr 16;234(2):120-30
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HeLa cells were subjected to SDS PAGE followed by western blot with 21612-1-AP(PFTK1 antibody) at dilution of 1:500
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human kidney using 21612-1-AP(PFTK1 antibody) at dilution of 1:100 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The PFTK1 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human PFTK1. This antibody recognizes human,mouse,rat antigen. The PFTK1 antibody has been validated for the following applications: ELISA, WB, IHC analysis.
